Comparing low-intensity shockwave and radial wave treatments for erectile dysfunction and pelvic pain

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of focused shockwave therapy (fSWT) versus radial wave therapy (rWT) in treating erectile dysfunction and chronic pelvic pain syndrome. Participants will be randomly assigned to receive either fSWT, rWT, or a sham treatment in a double-blind manner. Those with erectile dysfunction will be randomized in a 2:2:1 ratio, while patients with chronic pelvic pain syndrome will be assigned to fSWT with pelvic floor physical therapy or sham treatment. The study will assess the relief of symptoms and overall effectiveness of these therapies.

Why it matters

Who can join: the full rules

Erectile Dysfunction Group (ED) Inclusion Criteria (ED): (all of the following)

1. Cis-gendered heterosexual adult males18 years old
2. Stable relationship of more than 3 months duration with currently willing sexual partner and desire for penetration.
3. Mild to moderate organic erectile dysfunction (IIEF-EF score 11-25) in the last 3 months
4. If ED responsive or partially responsive to current use of PDE5I, participant must be willing to discontinue PDE5I for 4 weeks prior to trial and remain off PDE5I for the duration of the study. Partially responsive ED is defined as inadequate response for desired sexual activity, or poorly maintained erection despite initially good response.
5. Agreeable to attempt sexual intercourse at least 4 times per month for duration of study without being under the influence of alcohol or recreational drugs
6. Morning total testosterone level over 300ng/dL

Exclusion Criteria (ED):

1. Nerve-injury related ED (/spinal cord injury, severe lumbosacral disorder (radiculopathy, spinal stenosis) or other neurological disease affecting erectile functions (e.g, multiple sclerosis, alzheimer's disease, parkinsons disease, amyotrophic lateral sclerosis)
2. Untreated hypogonadism (morning total testosterone \<300 ng/dL) or on androgen deprivation therapy in the last 12 months
3. Predominately psychogenic ED based upon expert clinician opinion
4. Peyronie's disease, palpable plaque or curvature/penile anatomic abnormality that affects penetrative intercourse to any degree
5. History of non-superficial penile surgery (e.g, penile prosthesis, penectomy, plication, grafting)
6. History of penile injury or trauma (e.g, priapism, penile fracture)
7. Use of intracavernosal injection for ED within the last year
8. If diabetic, HbA1c 8% or higher within the past 12 months
9. Known corporal veno-occlusive dysfunction based on prior Doppler penile ultrasound
10. Current tobacco smoker, or has smoked in the past year
11. Poorly controlled hyperlipidemia
12. Poorly controlled hypertension
13. Severe cardiac disease or history of myocardial infarction
14. History of psychiatric disorder including bipolar disorder, current moderate or severe depression
15. Patients currently using SSRI or psychotropic medication
16. Severe ED based on IIEF-EF (score 10 or below)
17. Current acute prostatitis

Chronic Pelvic Pain Syndrome Group:

Inclusion Criteria (CPPS): (all of the following)

1. Adult males ≥18 years old
2. Chronic pelvic pain not explained by concurrent urinary tract infections. urine)
3. Willing to do PFPT

Exclusion criteria (CPPS):

1. Nerve-injury related pelvic pain (history of /spinal cord injury, severe lumbosacral disorder (radiculopathy, spinal stenosis) or other neurological disease affecting pain in the pelvic region(Multiple sclerosis, Alzheimer's, Parkinsons disease)
2. Acute prostatitis or any acute infection of the pelvic region
3. History of pelvic trauma

Where it's running

• Cleveland Clinic Foundation
  Cleveland, Ohio, United States Recruiting

Study contacts

• Principal investigator: Petar Bajic, MD — The Cleveland Clinic
• Study coordinator: Petar Bajic
• Email: bajicp@ccf.org
• Phone: 216-444-1231

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Platelet-Rich Plasma for Erectile Dysfunction After Prostate Surgery

  This trial tests whether injecting a patient’s own platelet-rich plasma can improve erectile function in men who have persistent ED more than a year after nerve-sparing radical prostatectomy.

  Recruiting Herlev and Gentofte Hospital · Herlev · NCT07863388

• Impact of an accessory pudendal artery on erection recovery after nerve-sparing prostate surgery

  This study checks if preserving an extra artery (the accessory pudendal artery) during robotic prostate removal helps men regain erections after nerve-sparing surgery.

  Recruiting University College, London · London · NCT07597798

• Injections of stem cells from fat tissue to treat erectile dysfunction

  This study is testing if injections of stem cells from fat can help men aged 30 to 75 with erectile dysfunction who haven't found relief from other treatments.

  Recruiting Jumeirah American Clinic · Dubai, Dubai · NCT06605508

• Pelvic floor training for men with chronic pelvic pain

  This study is testing if pelvic floor exercises and biofeedback can help men with chronic pelvic pain feel better over six months compared to those who continue their usual treatment.

  Recruiting Region Stockholm · Stockholm · NCT06115083

• A program to ease pelvic pain through cognitive behavioral therapy

  This study is testing a short program of cognitive behavioral therapy to see if it can help people with chronic pelvic pain feel better compared to regular patient education.

  Recruiting State University of New York at Buffalo · Los Angeles, California and 2 other locations · NCT05127616

• HIP2602 for Erectile Dysfunction: Testing a new treatment in adults

  This study tests whether HIP2602, alone or with related formulations, can improve erectile function in adult men with long-standing erectile dysfunction who partner with the same adult female partner.

  Recruiting Phase 3 Hanmi Pharmaceutical Company Limited · Busan · NCT07899073

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.